Structure Therapeutics Inc. American Depositary Shares (GPCR · NASDAQ)
GPCR · MARKET VIEW
Market view · as of Jun 29, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-0.35
vs $-0.35 est · in line
52-wk position
43.2%
-47.0% vs 52w high · +23.7% 1mo
Price (last ~year)
Valuation
- Market cap
- $3.53B
- P/B
- 2.442
- EV/EBITDA
- -13.46
- Beta
- -1.423
- Analyst target
- $104.59
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -15.0%
- ROA
- -11.6%
Price movement
- Last
- $49.71
- 1-month
- +23.7%
- 3-month
- +3.1%
- RSI (14)
- 93
- vs SMA200
- +1.7%
- 52-wk position
- 43.2% -47.0% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $0 | $-89.6M | $-76.2M | $-74.8M |
| 2025-12-31 | $0 | $24.0M | $33.0M | $33.6M |
| 2025-09-30 | $0 | $-73.8M | $-65.7M | $-65.3M |
| 2025-06-30 | $0 | $-70.5M | $-61.7M | $-61.2M |
Recent news
- Neutral Form 144 Structure Therapeutics Inc. For: 25 June By Investing.com · 2026-06-26
- Neutral Structure Therapeutics, Inc. Sponsored ADR Actuals & Estimates (NASDAQ:GPCR) · 2026-06-26
- Neutral Form 144 Structure Therapeutics Inc. For: 25 June By Investing.com · 2026-06-25
- Neutral Form 144 Structure Therapeutics Inc. For: 25 June By Investing.com · 2026-06-25
- Neutral GPCR Forecast — Price Target — Prediction for 2027 · 2026-06-25
- Neutral Shareholders Approve Directors, Auditors at 2026 Meeting · 2026-06-19
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)